Anzeige
Mehr »
Login
Dienstag, 01.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Kurs-Explosion voraus?: Diese kaum bekannte Aktie bohrt jetzt im Hotspot - und du erfährst es als Erster!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A4046T | ISIN: US69012T3059 | Ticker-Symbol: 41O
Tradegate
01.04.25
17:08 Uhr
1,150 Euro
+0,020
+1,77 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
OUTLOOK THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
OUTLOOK THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,0901,13021:33
1,0901,13021:33
ACCESS Newswire
350 Leser
Artikel bewerten:
(1)

JTC Team, LLC: Outlook Therapeutics to Participate Virtual Investor Closing Bell Series

Finanznachrichten News

Live webcast on Thursday, June 13th at 4:00 PM ET

FRENCHTOWN, NJ / ACCESSWIRE / June 12, 2024 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced that Outlook Therapeutics, Inc. (Nasdaq:OTLK), a biopharmaceutical company focused on the commercialization and development of ONS-5010/LYTENAVA (bevacizumab-vikg; bevacizumab gamma) for the treatment of retina diseases, will participate in the Virtual Investor Closing Bell Series on Thursday, June 13, 2024 at 4:00 PM ET.

As part of the event, Russell Trenary, President and Chief Executive Officer of Outlook Therapeutics, will provide a corporate overview and business outlook. In addition to the moderated discussion, investors and interested parties will have the opportunity to submit questions live during the event. The Company will answer as many questions as possible in the time allowed.

A live video webcast will be available on the Events page under the Investors section of the company's website (outlooktherapeutics.com). A webcast replay will be available two hours following the live event and will be accessible for 90 days.

About JTC Team

JTC is a fully integrated investor relations firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit www.jtcir.com or connect with the company on X and LinkedIn.

Contact:

Jenene Thomas
JTC Team, LLC
T: +1 (833) 475-8247
jtc@jtcir.com

SOURCE: JTC Team, LLC



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.